Aquinox Pharmaceuticals Announces Year End 2017 Financial Results
VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory …